Barclays’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.12M Buy
250,320
+71,787
+40% +$608K ﹤0.01% 2188
2025
Q1
$1.44M Sell
178,533
-65,415
-27% -$526K ﹤0.01% 2255
2024
Q4
$2.19M Buy
243,948
+24,617
+11% +$221K ﹤0.01% 2137
2024
Q3
$1.61M Buy
219,331
+143,072
+188% +$1.05M ﹤0.01% 2339
2024
Q2
$435K Sell
76,259
-96,465
-56% -$550K ﹤0.01% 2609
2024
Q1
$865K Sell
172,724
-45,723
-21% -$229K ﹤0.01% 2509
2023
Q4
$1.96M Buy
218,447
+90,719
+71% +$816K ﹤0.01% 2169
2023
Q3
$992K Buy
127,728
+77,594
+155% +$603K ﹤0.01% 2101
2023
Q2
$485K Sell
50,134
-17,819
-26% -$172K ﹤0.01% 2617
2023
Q1
$745K Buy
67,953
+3,230
+5% +$35.4K ﹤0.01% 2345
2022
Q4
$279K Sell
64,723
-592,079
-90% -$2.55M ﹤0.01% 2931
2022
Q3
$4.94M Sell
656,802
-384,252
-37% -$2.89M 0.01% 1108
2022
Q2
$10.5M Buy
1,041,054
+597,256
+135% +$6M 0.01% 810
2022
Q1
$5.49M Sell
443,798
-90,409
-17% -$1.12M ﹤0.01% 1135
2021
Q4
$12.2M Sell
534,207
-60,599
-10% -$1.39M ﹤0.01% 823
2021
Q3
$13.2M Buy
594,806
+403,950
+212% +$8.94M 0.01% 812
2021
Q2
$2.47M Sell
190,856
-224,404
-54% -$2.91M ﹤0.01% 1599
2021
Q1
$5.39M Buy
415,260
+256,236
+161% +$3.33M ﹤0.01% 1136
2020
Q4
$2.2M Sell
159,024
-63,000
-28% -$871K ﹤0.01% 1518
2020
Q3
$3.27M Buy
222,024
+144,338
+186% +$2.13M ﹤0.01% 1198
2020
Q2
$1.26M Hold
77,686
﹤0.01% 1780
2020
Q1
$1.13M Sell
77,686
-26,689
-26% -$387K ﹤0.01% 1654
2019
Q4
$2.12M Buy
104,375
+34,115
+49% +$691K ﹤0.01% 1842
2019
Q3
$376K Buy
70,260
+69,593
+10,434% +$372K ﹤0.01% 2759
2019
Q2
$4K Sell
667
-323
-33% -$1.94K ﹤0.01% 4086
2019
Q1
$6K Buy
+990
New +$6K ﹤0.01% 4051
2018
Q4
Hold
0
4086
2018
Q3
Sell
-30
Closed 4291
2018
Q2
$0 Sell
30
-990
-97% ﹤0.01% 4184
2018
Q1
$5K Buy
+1,020
New +$5K ﹤0.01% 4015
2017
Q4
Sell
-19,100
Closed -$120K 4063
2017
Q3
$120K Buy
19,100
+16,300
+582% +$102K ﹤0.01% 2627
2017
Q2
$17K Buy
+2,800
New +$17K ﹤0.01% 3310